Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buffered Lidocaine for Pain Control in Bladder Botox Injections
NCT04270526Phase 4Completed
- Sponsor
- Boston Urogynecology Associates
- Start
- Aug 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in overactive bladder (OAB) (2 arms), sponsored by Boston Urogynecology Associates. Primary endpoint: Visual Analogue Scale for Pain. Started Aug 2020; status: completed.
02
Drugs
lidocaine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT04270526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04270526.